Previous researches have shown that serum carcinoembryonic antigen (CEA) is a significant indicator of early detection, curative effect, recurrence, and prognostic in patients with CRC (Song et al., 2012; Tarantino et al., 2016; Werner et al., 2016). Here, CEACAM5 is linked to colorectal carcinoma.